Giorgio Stassi

Active 1997–2025

106
Papers
22,097
Citations
73
h-index
95
i10-index

Citations

Citations per year for Giorgio Stassi1943: 1 citations1995: 1 citations1997: 12 citations1998: 38 citations1999: 38 citations2000: 38 citations2001: 35 citations2002: 36 citations2003: 46 citations2004: 59 citations2005: 55 citations2006: 67 citations2007: 61 citations2008: 101 citations2009: 140 citations2010: 266 citations2011: 294 citations2012: 385 citations2013: 315 citations2014: 322 citations2015: 328 citations2016: 304 citations2017: 326 citations2018: 352 citations2019: 902 citations2020: 926 citations2021: 974 citations2022: 644 citations2023: 493 citations2024: 662 citations2025: 363 citations2026: 7 citations1944–1994: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,260 citing papers, 22.9% of this breakdownChina: 1,698 citing papers, 17.2% of this breakdownItaly: 747 citing papers, 7.6% of this breakdownGermany: 489 citing papers, 4.9% of this breakdownUnited Kingdom: 455 citing papers, 4.6% of this breakdownJapan: 325 citing papers, 3.3% of this breakdownFrance: 305 citing papers, 3.1% of this breakdownCanada: 246 citing papers, 2.5% of this breakdownNetherlands: 241 citing papers, 2.4% of this breakdownSpain: 227 citing papers, 2.3% of this breakdownIndia: 222 citing papers, 2.2% of this breakdownAustralia: 219 citing papers, 2.2% of this breakdown
0%22.9%Other 24.8%

Fields

  • Medicine47.4%
  • Biochemistry, Genetics and Molecular Biology39.2%
  • Immunology and Microbiology8.1%
  • Engineering1.7%
  • Neuroscience1.1%
  • Materials Science0.8%
  • Other1.7%

Topics

  • Cancer Cells and Metastasis11.5%
  • Cancer, Hypoxia, and Metabolism3.9%
  • Epigenetics and DNA Methylation3.5%
  • Immune Cell Function and Interaction2.3%
  • Cancer Genomics and Diagnostics2%
  • MicroRNA in disease regulation1.9%
  • Other74.9%

Coauthors

All papers

Open in search
  1. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

    Authors: , , , , , - Molecular Cancer 2019 cited by 657

  2. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

    Authors: , , , , , , , , , , , , , , - Nature Cell Biology 2010 cited by 1,788

  3. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

    Authors: , , , , , , , , , , - Nature 2010 cited by 1,379

  4. CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis

    Authors: , , , , , , , , , , , , , - Cell stem cell 2014 cited by 726

  5. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2022 cited by 134

  6. Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4

    Authors: , , , , , , , , , , - Cell stem cell 2007 cited by 1,038

  7. Cancer stem cell definitions and terminology: the devil is in the details

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2012 cited by 690

  8. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment

    Authors: , , , , , , , , , , , , , , , , - Cell Death and Disease 2014 cited by 271

  9. Tumor and its microenvironment: A synergistic interplay

    Authors: , , , , , - Seminars in Cancer Biology 2013 cited by 457

  10. Epithelial–mesenchymal transition: a new target in anticancer drug discovery

    Authors: , , - Nature Reviews Drug Discovery 2016 cited by 353

  11. Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2009 cited by 1,169

  12. Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer

    Authors: , , , , , , , , , , , - OncoImmunology 2017 cited by 170

  13. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gut 2021 cited by 100

  14. Lipid Droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging

    Authors: , , , , , , , , , , , , , , , , , - Stem Cells 2014 cited by 258

  15. Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Immunology 2013 cited by 249

  16. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 81

  17. Meeting the Challenge of Targeting Cancer Stem Cells

    Authors: , , , , , , - Frontiers in Cell and Developmental Biology 2019 cited by 150

  18. In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

    Authors: , , , , , , , , , , , , , , , - Clinical & Experimental Immunology 2010 cited by 289

  19. Efficient Killing of Human Colon Cancer Stem Cells by γδ T Lymphocytes

    Authors: , , , , , , , , , , , - The Journal of Immunology 2009 cited by 274

  20. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Death and Differentiation 2018 cited by 181

  21. Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2009 cited by 735

  22. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 720

  23. Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2018 cited by 172

  24. Targeting Phosphatases and Kinases: How to Checkmate Cancer

    Authors: , , , , , , , , , , , , - Frontiers in Cell and Developmental Biology 2021 cited by 63